Detection of tumour cells in bone marrow, peripheral blood and leukapheresis products in patients with breast cancer;Tumorzellnachweis in knochenmark, peripherem blut und leukaphereseprodukten bei patientinnen mit mammakarzinom

Deutsche Medizinische Wochenschrift

Volumn 125, Issue 27, 2000, Pages 840-844

  Zhong, X Y ^a,b  

^a UNIVERSITY WOMEN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SMEAR; BONE MARROW; BREAST CANCER; DIAGNOSTIC APPROACH ROUTE; REVIEW; TUMOR CELL;

BLOOD CELLS; BONE MARROW CELLS; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKAPHERESIS; MAGNETICS; NEOPLASM CIRCULATING CELLS; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 0034617237     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7012     Document Type: Review

References (51)

1. 1 Bell J. The polymerase chain reaction. Immunol Today 1989; 10: 351-355
2. 2 Berger U, Bettelheim R, Mansi JL, Easton D, Coombes RC, Neville AM. The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Amer J Clin Pathol 1988; 90: 1-6
3. 3 Bergsagel PL, Victor-Kobrin C, Timblin CR, Trepel J, Kuehl WM. A murine cDNA encodes a pan-epithelial glycoprotein that is also expressed on plasma cells. J Immunol 1992; 148: 590-596
4. 4 Brugger W, Bross KJ, Glatt M, Weber E, Mertelmann R, Kanz L. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994; 83: 636-640
5. 5 Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P. Detection of epithelial cancer cells in perpheral blood reverse transcriptase-polymerase chain reaction. Brit J Cancer 1995; 71: 278-281
6. 6 Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 1991; 9: 1749-1756
7. 7 Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS. Sensitive detection of occult Breast cancer by the reverse-transcriptase polymerase chain reaction. Journal of Clinical Oncology 1994; 12: 475-482
8. 8 Delsol G, Gatter KC, Stein H, Erber WN, Pulfod KAE, Zinne K, Mason DY. Human lymphoid cells express epithelial menbrane antigen. Lancet 1984; 2: 1124-1128
9. 9 Dearnaley DP, Sloane JP, Ormerod MG, Steele K, Coombes RC, Clink HM, Powles TJ, Ford HAT, Gazet JC, Neville AM. Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer 1981; 44: 85-90
10. 10 Diel IJ, Kaufmann M, Goerner R, Costa SD, Kaul S, Bastert G. Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastasis. J Clin Oncol 1992; 10: 1534-1539
11. 11 Diel IJ, Kaufmann M, Costa SD, Bastert G. Monoclonal antibodies to detect breast cancer cells in bone marrow.. Lippincott Company, Philadelphia, 1994: 143-164
12. 12 Diel IJ, Kaufmann M, Solomayer EF, Wallwiener D, Gollan C, Goerner R, Kaul S, Costa SD, von Minckwitz G, Holle R, Bastert G. Prognostische Bedeutung des Tumorzellnachweises im Knochenmark im Vergleich zum Nodalstatus beim primären Mammakarzinom. Geburtsh Frauenheilk 1997; 57: 333-341
13. 13 Fodstad, Hoifodt HK, Rye PD. New immunobead techniques for sensitive detection of malignant cells in blood and bone marrow. Proc Am Assoc Cancer Res 1996; 37: 214
14. 14 Franke WW, Schller DL, Moll R, Winter S, Schmid E, Engelbrecht E, Denk H, Krepler R, Platzer B. Diversity of Cytokeratins. Differatiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. J Mol Biol 1981; 153: 933-959
15. 15 Funke I, Schraut W. Meta-analyses of studies on bone marrow micrometastases: An independent prognostic impact remains to be substantiated. J Clin Oncol 1998; 16: 557-566
16. 16 Gebhardt F, Zanker KS, Brandt B. Differential expression of alternatively spliced c-erbB-2 mRNA in primary tumors, lymph node metastases, and bone marrow micrometastases from breast cancer patients. Biochem Biophys Res Commun 1998; 247: 319-323
17. 17 Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M. Specific detection of Carcinoembryonic antigen-expressing turmor cells in bone marrow aspirates by polymerase chain reaction. Journal of Clinical Oncology 1994; 12: 725-729
18. 18 Gold P, Freedman SO. Demonstration of tumor specific antigens in human colonic carcinomata by immunologic tolerance and absorption techniques. J Exp Med 1965; 121: 439-462
19. 19 Graaf DH, Gunhild M., MÆlandsmo , Ruun P, Forus A, Fojord T, Fodstad, Hovig E. Ectopic Expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP-2. Int J Cancer 1997; 72: 191-196
20. 20 Kaul S., Zhong XY, Diel I, Bastert G. Tumor cell contamination (TC) in bone marrow of breast cancer patients: Improved sensitivity and quantification of tumor cells using BM2-immunomagnetic beads. Arch of Gyneco Obstet 1996; 258: 192
21. 21 Kimoto Y. A possibility of all mRNA expression in a human single lymphocyte. Hum Cell 1996; 9: 367-370
22. 22 Krismann M, Todt B, Schröder J, Gareis D, Müller KM, Seeber S, Schütte J. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. Journal of Clinical Oncology 1995; 13: 2769-2775
23. 23 Kvalheim G, Fjeld JG, Pihl A. Immunomagnetic removal of B-Lymphoma cells using a novel mono-sized magnetizable polymer bead, M-280, in conjunction with primary IgM and IgG antibodies. Bone Marrow Transplant 1989; 4: 567
24. 24 Landys K, Persson S, Kovarik J, Hultborn R, Holmberg E. Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median follow-up. Breast Cancer Res Treat 1998; 49: 27-33
25. 25 Luke S, Kaul K. Detection of breast cancer cells inblood using immunomagnetic bead selection and reverse transcription-polymerase chain reaction. Mol Diagn 1998; 3: 149-155
26. 26 Moreno JG, Croce CM, Fischer R, Monne M, Vihko P, Mulholland G, Gomella LG. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 1992; 52: 6110-6112
27. 27 Myers TW, Gelfand DH. Reverse transcription and DNA amplification by a Thermus thermophilus DANN polymerase. Biochemistry 1991; 30: 7661-7666
28. 28 Naito H, Kuzumaki N, Uchino J, Kobayashi R, Shikano T, Ishikawa Y, Matsumoto S. Detection of Tyrosine Hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription polymerase chain reaction. Eur J Cancer 1991; 27: 762-765
29. 29 Naume B, Borgen E, Nesland JM, Beiske K, Gilen E, Renolen A, Ravnas G, Qvist H, Karesen R, Kvalheim G. Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation. Int J Cancer 1998; 78: 556-560
30. 30 Noguchi S, Aihara T, Nakamori S, Motomura K, Inaji H, Imaoka S, Koyama H. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 1994; 74: 1595-1600
31. 31 Pantel K, Schlimok G, Angstwurm M, Weckermann C, Schmaus W, Gath H, Passlick B., Izbicki J, Riethmüller G. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 1994; 3: 165-173
32. 32 Pantel K, Braun S, Passlick B, Schlimok G. Minimal residual epithelial cancer: Diagnostic approaches and prognostic relevance.. Gustav Fischer Verlag, Stuttgart, New York, 1996
33. 33 Peters WP, Ross M, Vredenburgh JJ, Meisenberg B, Marks LB, Winer E, Kurtzberg J, Bast RC, Jones R, Shpall E. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 1993; 11: 1132-1143
34. 34 Ross AA., Cooper BM, Lazarus HM, Mackay W, Moss TJ, Cibanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assy techniques. Blood 1993; 82: 2605-2610
35. 35 Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-1354
36. 36 Schildberg FW, Kiffner E. Interdisziplinäre Therapie des Mammakarzinoms.. perimed Fachbuch-Verlagsgesellschaft mbH, 1985
37. 37 Schlimok G, Funke I, Bock B, Schweiberer B, Witte J, Riethmuller G. Epithelial tumor cells in bone marry of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 1990; 8: 831-837
38. 38 Schlimok G, Pantel K, Loibner H, Fackler-Schwalbe I, Riethmüller G. Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a noval surrogate test to monitor adjuvant therapies of solid tumours. Eur J Cancer 1995; 31: 1799-1803
39. 39 Schlimok G. Techniken zur Erkennung minimal residueller Erkrankung. Zytologie Onkolge 1997; 3: 293-297
40. 40 Shea TC, Mason JR, Storniolo , AM . Sequential cycles of high-dose carboplatin administered with recombinant granulocyte-macrophage colony-stimulating factor and repeated infusion of autologous peripheral blood progenitor cells: A novel and effective method for delivering multiple courses of dose-intensive therapy. J Clin Oncol 1992; 10: 464-473
41. 41 Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 338: 1227-1229
42. 42 Sohn C, Baudendistel A, Thiel C, Kaufmann M, Bastert G. Die sonographisch nachgewiesene Gefäßdichte: Ein neuer Prognosefaktor?. Zbl Gynäk 1996; 118
43. 43 Untch M, Harbeck N, Eiermann W. Micrometastases in bone marrow in patients with breast cancer. British Medical Journal 1988; 296: 290
44. 44 Zhong XY, Kaul S, Diel I, Bastert G. Tumor cell contamination (TC) in bone marrow of breast cancer patients: sensitive detection by reverse transcriptase-polymerase chain reactions for MUC1, CEA, keratin 19 and GA733-2. Arch of Gyneco Obstet 1996; 258: 92
45. 45 Zhong YX, Kaul S, Eichner A, Bastert G. Low specificity of MUC1 as a marker to detect epithelial cancer dissemination in human bone marrow and blood. Clin Lab 1998; 44: 971-978
46. 46 Zhong YX, Kaul S, Eichner A, Diel I, Bastert G. Analysis of sensitivity and specificity of cytokeratin 19 reverse transcriptase polymerase chain reaction for detection of occult breast cancer in bone marrow and leukapheresis products. Cancer Res and Clin Oncol 1999; 125: 286-291
47. 47 Zhong YX, Kaul S, Eichner A, Bastert G. Evaluating GA733-2 mRNA as a marker for the detection of micrometastatic breast cancer in peripheral blood and bone marrow.. Arch of Gyneco Obstet, 1999: 263: 2-7
48. 48 Zhong YX, Kaul S, Eichner A, Diel I, Bastert G. Sensitivity and specificity of immunocytochemistry for the detection of tumor cells in the bone marrow of patients with breast cancer. Tumor Diagnostik 1999c; 20: 39-44
49. 49 Zhong YX, Kaul S, Eichner A, Bastert G. Evaluation of carcinoembryonic antigen reverse transcriptase-polymerase chain reaction for the detection of breast cancer dissemination in bone marrow and peripheral blood.. Cancer Res and Clin Oncol, 1999: 125: 669-675
50. 50 Lin YS, Zhong XY, Hohaus S, Kaul S, Haas R. Detection of tumor cells in leukapheresis products from patients with breast cancer using immunocytochemical staining method. Arch of Gyneco Obstet, 2000: 263: 119-126
51. 51 Zhong XY, Kaul S, Lin YS, Eichler A, Bastert G. Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase polymerase chain reaction for cytokeratin-19. Cancer Res and Clin Oncol, 2000: 126: 212-218